← All trials
NCT05031780
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 31, 2021
- Primary completion
- Sep 30, 2025
- Completion date
- Jan 31, 2030
- First posted
- Sep 2, 2021
- Last posted
- Nov 18, 2021
- Enrollment
- 267
- Arms / groups
- 7 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Agios Pharmaceuticals, Inc.Lead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.